A detailed history of Kimelman & Baird, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kimelman & Baird, LLC holds 162,900 shares of MRK stock, worth $16.2 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares
162,900
Previous 163,560 0.4%
Holding current value
$16.2 Million
Previous $20.2 Billion 8.64%
% of portfolio
1.48%
Previous 1.67%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$111.15 - $128.97 $73,359 - $85,120
-660 Reduced 0.4%
162,900 $18.5 Billion
Q2 2024

Aug 19, 2024

SELL
$123.8 - $132.96 $21.6 Million - $23.2 Million
-174,129 Closed
0 $0
Q2 2021

Aug 17, 2021

BUY
$70.31 - $77.77 $319,769 - $353,697
4,548 Added 2.68%
174,129 $13.5 Million
Q3 2019

Dec 10, 2019

SELL
$76.08 - $82.93 $7,608 - $8,293
-100 Reduced 0.06%
169,581 $14.3 Million
Q2 2019

Nov 22, 2019

BUY
$69.84 - $81.59 $11.9 Million - $13.8 Million
169,681 New
169,681 $14.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Kimelman & Baird, LLC Portfolio

Follow Kimelman & Baird, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kimelman & Baird, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kimelman & Baird, LLC with notifications on news.